| Stock | Market Cap |
Dividend Yield | P/E Ratio | Dividend Frequency |
Years Paying |
DGR |
|
000411.SZ ZHEJIANG INTL GP C
|
783.1 million |
0.03% |
10.88
|
- |
6 |
-
|
|
000705.SZ Z/ZHENYUAN SHARE C
|
376.6 million |
0.01% |
47.69
|
- |
6 |
-
|
|
000908.SZ Hunan Jingfeng Pharmaceutical Co.,Ltd.
|
829.2 million |
0.00% |
35.44
|
- |
- |
-
|
|
000952.SZ Hubei Guangji Pharmaceutical Co., Ltd.
|
395.0 million |
0.00% |
-11.51
|
- |
- |
-
|
|
002019.SZ YIFAN PHARMACEUTIC
|
1.9 billion |
0.01% |
-38.37
|
- |
1 |
-
|
|
002198.SZ GUANGDONG JIAYING
|
515.1 million |
0.01% |
343.50
|
- |
1 |
-
|
|
002422.SZ SICHUAN KELUN PHAR
|
7.0 billion |
0.02% |
15.46
|
- |
14 |
30%
|
|
004720.KS PharmGen Science, Inc.
|
45.2 million |
- |
-
|
- |
- |
-
|
|
039200.KQ Oscotec Inc.
|
1.2 billion |
- |
-
|
- |
- |
-
|
|
0QQ6.L Roche Holding AG
|
387.5 billion |
2.64% |
22.66
|
1 |
12 |
1%
|
|
1093.HK CSPC Pharmaceutical Group Limited
|
12.9 billion |
3.16% |
23.97
|
2 |
14 |
12%
|
|
118000.KS Metacare Co., Ltd.
|
35.9 million |
- |
-
|
- |
- |
-
|
|
1643.HK Modern Chinese Medicine Group Co., Ltd.
|
128.6 million |
0.00% |
35
|
- |
- |
-
|
|
1666.HK Tong Ren Tang Technologies Co. Ltd.
|
691.1 million |
4.65% |
10.85
|
1 |
26 |
2%
|
|
200780.KQ BCWORLD PHARM. Co., Ltd.
|
35.7 million |
1.94% |
-
|
1 |
12 |
-2%
|
|
2630.HK Vigonvita Life Sciences Co., Ltd.
|
1.4 billion |
0.00% |
-
|
- |
- |
-
|
|
300006.SZ Chongqing Lummy Pharmaceutical Co., Ltd.
|
819.0 million |
0.00% |
-47.73
|
- |
- |
-
|
|
300109.SZ NKY MEDICAL HOLDIN
|
1.0 billion |
0.05% |
18.27
|
- |
14 |
30%
|
|
300357.SZ ZHEJIANG WOLWO BIO
|
1.5 billion |
0.96% |
32.62
|
- |
10 |
-1%
|
|
4102.TWO Yung Zip Chemical Ind. Co., Ltd.
|
26.2 million |
0.00% |
24.28
|
- |
5 |
30%
|
|
4151.T Kyowa Kirin Co., Ltd.
|
7.3 billion |
2.75% |
16.89
|
2 |
27 |
8%
|
|
4503.T Astellas Pharma Inc.
|
25.8 billion |
3.26% |
33.50
|
2 |
27 |
14%
|
|
4519.T Chugai Pharmaceutical Co., Ltd.
|
97.3 billion |
1.38% |
36.36
|
2 |
27 |
30%
|
|
4528.T Ono Pharmaceutical Co., Ltd.
|
7.3 billion |
3.17% |
22.54
|
2 |
26 |
12%
|
|
4536.T Santen Pharmaceutical Co., Ltd.
|
3.2 billion |
2.34% |
17.51
|
2 |
26 |
5%
|
|
4552.T JCR Pharmaceuticals Co., Ltd.
|
474.7 million |
3.17% |
-33.42
|
2 |
21 |
23%
|
|
4568.T Daiichi Sankyo Company, Limited
|
32.7 billion |
2.72% |
19.14
|
2 |
27 |
18%
|
|
4578.T Otsuka Holdings Co., Ltd.
|
32.8 billion |
1.39% |
14.69
|
2 |
16 |
9%
|
|
464280.KQ Tdspharm
|
32.9 million |
- |
-
|
- |
- |
-
|
|
4882.T Perseus Proteomics Inc.
|
20.4 million |
0.00% |
-4.21
|
- |
- |
-
|
|
4AB.DE AbbVie Inc.
|
358.5 billion |
3.71% |
104.03
|
4 |
11 |
0%
|
|
600276.SS Jiangsu Hengrui Medicine Co., Ltd.
|
56.6 billion |
0.36% |
48.80
|
1 |
26 |
30%
|
|
600436.SS Zhangzhou Pientzehuang Pharmaceutical., Ltd
|
14.1 billion |
2.04% |
39.23
|
2 |
22 |
30%
|
|
600613.SS Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.
|
453.9 million |
2.34% |
58.27
|
1 |
5 |
30%
|
|
600666.SS Aurora Optoelectronics Co.,Ltd.
|
1.6 billion |
0.00% |
80.40
|
- |
- |
-
|
|
600671.SS Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd
|
378.4 million |
0.00% |
77.89
|
- |
- |
-
|
|
600713.SS NanJing Pharmaceutical Company Limited
|
1.0 billion |
3.17% |
14.13
|
1 |
11 |
6%
|
|
600771.SS GuangYuYuan Chinese Herbal Medicine Co., Ltd.
|
1.2 billion |
0.00% |
99.94
|
- |
- |
-
|
|
6130.TWO Shangya Technology Co., Ltd.
|
52.0 million |
1.32% |
-22.24
|
- |
- |
-
|
|
6MK.DE Merck & Co., Inc.
|
279.1 billion |
2.87% |
15.71
|
4 |
27 |
3%
|
|
7630.HK IMPACT THERAP-B
|
1.3 billion |
0.00% |
-
|
- |
- |
-
|
|
ABBOTINDIA.BO Abbott India Limited
|
5.9 billion |
1.77% |
37.76
|
1 |
26 |
3%
|
|
ABBOTINDIA.NS Abbott India Limited
|
6.0 billion |
1.74% |
38.06
|
1 |
19 |
19%
|
|
ABBV AbbVie Inc.
Contenders
|
450.1 billion |
2.65% |
101.05
|
4 |
14 |
6%
|
|
ABBV.BA AbbVie Inc.
|
414.2 billion |
2.24% |
10.31
|
4 |
6 |
30%
|
|
ABBV.NE AbbVie Inc.
|
450.0 billion |
18.12% |
190.53
|
3 |
4 |
-
|
|
ALPMF ASTELLAS PHARMA
|
18.4 billion |
6.86% |
563.55
|
3 |
21 |
18%
|
|
ALPMY Astellas Pharma Inc.
|
23.8 billion |
3.45% |
13.70
|
3 |
18 |
8%
|
|
AMG.DE Amgen Inc.
|
174.3 billion |
3.51% |
22.93
|
4 |
16 |
5%
|
|
AMGN Amgen Inc.
Contenders
|
201.9 billion |
2.62% |
23.04
|
4 |
16 |
8%
|
|
AMRN Amarin Corporation plc
|
338.6 million |
0.00% |
-
|
- |
- |
-
|
|
AZN AstraZeneca PLC
|
294.9 billion |
1.68% |
27.34
|
2 |
34 |
2%
|
|
AZNCF AstraZeneca PLC
|
312.8 billion |
1.56% |
33.46
|
3 |
18 |
24%
|
|
AZN.L AstraZeneca PLC
|
3.2 billion |
1.57% |
30.86
|
2 |
34 |
6%
|
|
AZN.ST AstraZeneca PLC
|
271.2 billion |
0.19% |
27.37
|
2 |
27 |
4%
|
|
BAYN.DE Bayer AG
|
42.5 billion |
0.29% |
-
|
1 |
27 |
-23%
|
|
BAYN.F Bayer Aktiengesellschaft
|
59.9 billion |
0.21% |
28.65
|
1 |
21 |
-23%
|
|
BAYN.SG Bayer AG
|
40.9 billion |
0.30% |
-
|
1 |
17 |
-23%
|
|
BAYRY Bayer AG
|
57.5 billion |
0.22% |
-
|
1 |
32 |
-26%
|
|
BAY.WA Bayer AG
|
42.9 billion |
0.28% |
-196.43
|
1 |
10 |
-24%
|
|
BIIB Biogen Inc.
|
31.9 billion |
0.00% |
20.34
|
- |
- |
-
|
|
BMY Bristol-Myers Squibb Company
Contenders
|
115.8 billion |
4.43% |
15.85
|
4 |
55 |
6%
|
|
BRM.DE Bristol-Myers Squibb Company
|
120.3 billion |
4.16% |
17.30
|
4 |
28 |
0%
|
|
CELG-RI Bristol-Myers Squibb Company Ce
|
181.7 million |
0.00% |
-
|
- |
- |
-
|
|
CHGCY Chugai Pharmaceutical Co., Ltd.
|
76.2 billion |
3.75% |
28.59
|
- |
- |
-
|
|
CIPLA.BO Cipla Limited
|
11.1 billion |
0.98% |
23.52
|
1 |
27 |
30%
|
|
CIPLA.NS Cipla Limited
|
11.0 billion |
0.99% |
23.35
|
1 |
30 |
30%
|
|
CMOPF COSMO PHARMACEUTICALS N.V.
|
1.3 billion |
0.03% |
112.68
|
- |
- |
-
|
|
COPN.SW Cosmo Pharmaceuticals N.V.
|
1.3 billion |
3.12% |
19.73
|
1 |
5 |
20%
|
|
CRXT Clarus Therapeutics Holdings, Inc.
|
2.5 million |
- |
-
|
- |
- |
-
|
|
CRXTW Clarus Therapeutics Holdings, Inc.
|
- |
- |
-
|
- |
- |
-
|
|
CSPCY CSPC Pharmaceutical Group Limited
|
11.1 billion |
3.87% |
19.45
|
2 |
8 |
12%
|
|
DCHPF Dechra Pharmaceuticals PLC
|
5.5 billion |
1.16% |
106.82
|
1 |
8 |
15%
|
|
DPH.L Dechra Pharmaceuticals PLC
|
59.5 million |
1.20% |
-154.72
|
1 |
23 |
13%
|
|
DSKYF Daiichi Sankyo Company, Limited
|
28.6 billion |
3.23% |
17.01
|
2 |
40 |
22%
|
|
DSNKY Daiichi Sankyo Company, Limited
|
29.9 billion |
3.00% |
17.61
|
- |
- |
-
|
|
FRE.AX Firebrick Pharma Limited
|
10.3 million |
0.00% |
-5.80
|
- |
- |
-
|
|
GIFLF Grifols, S.A.
|
7.9 billion |
1.54% |
17.94
|
- |
- |
-
|
|
GIFOF Grifols, S.A.
|
8.7 billion |
2.03% |
13.62
|
- |
- |
-
|
|
GIKLY Grifols, S.A.
|
13.4 billion |
0.93% |
14.46
|
1 |
2 |
-
|
|
GILD Gilead Sciences, Inc.
Contenders
|
163.0 billion |
2.45% |
18.13
|
4 |
12 |
2%
|
|
GIS.DE Gilead Sciences, Inc.
|
161.8 billion |
2.76% |
18.20
|
4 |
12 |
-1%
|
|
GLAND.BO Gland Pharma Limited
|
2.9 billion |
1.05% |
33.30
|
1 |
3 |
-
|
|
GLAND.NS Gland Pharma Limited
|
2.9 billion |
1.05% |
33.27
|
1 |
3 |
-
|
|
GLAXF GSK plc
|
103.3 billion |
3.48% |
12.96
|
8 |
23 |
9%
|
|
GLAXO.BO GlaxoSmithKline Pharmaceuticals Limited
|
4.4 billion |
1.67% |
44.63
|
1 |
26 |
30%
|
|
GLAXO.NS GlaxoSmithKline Pharmaceuticals Limited
|
4.4 billion |
1.69% |
41.11
|
1 |
24 |
30%
|
|
GRF.MC Grifols, S.A.
|
8.0 billion |
1.46% |
18.64
|
2 |
2 |
-
|
|
GRFS Grifols, S.A.
|
6.1 billion |
3.77% |
11.14
|
- |
2 |
-
|
|
GSK GSK plc
|
106.8 billion |
3.38% |
13.05
|
4 |
43 |
0%
|
|
GSK.L GSK plc
|
1.2 billion |
3.39% |
15.27
|
4 |
34 |
-4%
|
|
GSKN.MX GSK PLC
|
82.9 billion |
0.00% |
9.68
|
2 |
16 |
-5%
|
|
GWPH GW Pharmaceuticals plc
|
6.8 billion |
0.70% |
-98.63
|
- |
- |
-
|
|
H02.SI Haw Par Corporation Limited
|
2.7 billion |
2.59% |
13.67
|
2 |
27 |
30%
|
|
HAWPF HAW PAR CORP LTD
|
1.6 billion |
0.06% |
-
|
- |
- |
-
|
|
HAWPY Haw Par Corporation Limited
|
1.6 billion |
1.22% |
14.25
|
2 |
9 |
17%
|
|
HZNP Horizon Therapeutics Public Limited Company
|
23.4 billion |
- |
61.86
|
- |
- |
-
|
|
IDP.DE Biogen Inc.
|
27.3 billion |
0.00% |
20.29
|
- |
- |
-
|
|
JCRRF JCR Pharmaceuticals Co., Ltd.
|
1.1 billion |
1.65% |
20.55
|
2 |
4 |
-
|
|
JNJ Johnson & Johnson
Champions
|
601.7 billion |
1.05% |
28.67
|
4 |
26 |
5%
|
|
JNJ.DE Johnson & Johnson
|
609.6 billion |
2.40% |
29.23
|
4 |
27 |
2%
|
|
JNJ.NE JOHNSON & JOHNSON CDR (CAD HEDG
|
621.9 billion |
15.11% |
24.19
|
4 |
4 |
-
|
|
KLBF.JK Kalbe Farma Tbk
|
2.8 billion |
0.00% |
16.49
|
- |
18 |
22%
|
|
KOPRAN.BO Kopran Limited
|
61.6 million |
2.44% |
35.95
|
1 |
6 |
-
|
|
KOPRAN.NS Kopran Limited
|
61.6 million |
2.44% |
35.91
|
1 |
6 |
-
|
|
KYKOF Kyowa Kirin Co., Ltd.
|
7.6 billion |
2.91% |
17.59
|
2 |
41 |
-4%
|
|
LLY Eli Lilly and Company
Contenders
|
1.1 trillion |
0.54% |
35.03
|
4 |
55 |
16%
|
|
LLY.DE Eli Lilly and Company
|
935.7 billion |
0.62% |
44.18
|
4 |
11 |
12%
|
|
LLY.SW LILLY ELI
|
928.9 billion |
0.75% |
75.02
|
2 |
- |
-
|
|
MARKSANS.BO Marksans Pharma Limited
|
816.9 million |
0.46% |
22.38
|
1 |
13 |
-
|
|
MARKSANS.NS Marksans Pharma Limited
|
806.0 million |
0.47% |
21.55
|
1 |
12 |
-
|
|
MAYNF Mayne Pharma Group Limited
|
134.1 million |
0.00% |
-2.21
|
- |
- |
-
|
|
MDCX Medicus Pharma Ltd. Common Stock
|
10.1 million |
0.00% |
-
|
- |
- |
-
|
|
MDCXW Medicus Pharma Ltd.
|
19.2 million |
0.00% |
-
|
- |
- |
-
|
|
MIRA MIRA Pharmaceuticals, Inc.
|
39.7 million |
0.00% |
-0.72
|
- |
- |
-
|
|
MRK Merck & Co., Inc.
Contenders
|
313.1 billion |
2.65% |
31.99
|
4 |
65 |
6%
|
|
MYX.AX Mayne Pharma Group Limited
|
144.5 million |
0.00% |
-2.44
|
- |
- |
-
|
|
NGLFINE.BO NGL Fine-Chem Limited
|
152.6 million |
0.07% |
41.55
|
1 |
8 |
13%
|
|
NGLFINE.NS NGL Fine-Chem Limited
|
149.9 million |
0.07% |
40.82
|
1 |
8 |
13%
|
|
NONOF Novo Nordisk A/S
|
218.1 billion |
3.68% |
10.69
|
3 |
18 |
27%
|
|
NOV.DE Novo Nordisk A/S
|
206.4 billion |
29.35% |
11.07
|
2 |
25 |
4%
|
|
NOVN.SW Novartis AG
|
269.0 billion |
4.03% |
21.04
|
1 |
30 |
4%
|
|
NOVO-B.CO Novo Nordisk A/S
|
205.2 billion |
3.90% |
11.01
|
2 |
27 |
8%
|
|
NSRX Nasus Pharma Ltd.
|
30.4 million |
0.00% |
-23.81
|
- |
- |
-
|
|
NVO Novo Nordisk A/S
|
218.9 billion |
3.66% |
10.79
|
2 |
45 |
26%
|
|
NVON.NE NOVO NORDISK CDR (CAD HEDGED)
|
16.7 billion |
228.07% |
0.90
|
2 |
2 |
-
|
|
NVS Novartis AG
Challengers
|
305.1 billion |
2.96% |
21.00
|
1 |
30 |
6%
|
|
NVSEF Novartis AG
|
301.9 billion |
3.00% |
21.02
|
2 |
30 |
5%
|
|
OGN Organon & Co.
|
3.6 billion |
0.59% |
14.31
|
4 |
6 |
-8%
|
|
OPHLF Ono Pharmaceutical Co., Ltd.
|
9.1 billion |
3.43% |
10.09
|
3 |
19 |
26%
|
|
OPHLY Ono Pharmaceutical Co., Ltd.
|
7.0 billion |
2.70% |
16.16
|
- |
- |
-
|
|
ORINF Orion Oyj
|
5.6 billion |
4.55% |
28.43
|
1 |
18 |
16%
|
|
ORINY Orion Oyj
|
6.1 billion |
4.24% |
30.23
|
1 |
8 |
14%
|
|
ORNAV.HE Orion Oyj
|
10.7 billion |
2.69% |
17.58
|
2 |
27 |
-2%
|
|
ORNBV.HE Orion Oyj
|
12.5 billion |
2.62% |
18.52
|
2 |
27 |
-2%
|
|
OTSKY Otsuka Holdings Co., Ltd.
|
38.1 billion |
1.21% |
15.72
|
- |
- |
-
|
|
PFE Pfizer Inc.
Contenders
|
138.6 billion |
7.07% |
19.60
|
4 |
55 |
0%
|
|
PFE.BA Pfizer Inc.
|
145.5 billion |
0.00% |
2.62
|
4 |
19 |
30%
|
|
PFE.DE Pfizer Inc.
|
148.9 billion |
6.43% |
19.53
|
4 |
27 |
-2%
|
|
PFE.F Pfizer Inc.
|
147.1 billion |
7.56% |
19.41
|
4 |
17 |
0%
|
|
PFE.NE Pfizer Inc.
|
146.8 billion |
14.14% |
14.81
|
4 |
5 |
15%
|
|
PFIZER.BO Pfizer Limited
|
2.3 billion |
0.72% |
26.50
|
- |
12 |
30%
|
|
PFIZER.NS Pfizer Limited
|
2.3 billion |
0.71% |
26.32
|
- |
12 |
30%
|
|
PNVL3.SA Dimed S.A. Distribuidora de Medicamentos
|
446.7 million |
2.27% |
20.27
|
4 |
27 |
12%
|
|
PSYG.CN Psyence Group Inc.
|
1.3 million |
0.00% |
-0.12
|
- |
- |
-
|
|
PSYGF Psyence Group Inc.
|
2.0 million |
0.00% |
-0.17
|
- |
- |
-
|
|
REC.MI Recordati Industria Chimica e Farmaceutica S.p.A.
|
11.2 billion |
2.73% |
24.54
|
2 |
32 |
4%
|
|
RHHBF Roche Holding AG
|
344.7 billion |
2.87% |
23.47
|
2 |
25 |
26%
|
|
RHHBY Roche Holding AG
|
341.6 billion |
2.92% |
22.25
|
1 |
34 |
3%
|
|
RHHVF Roche Holding AG
|
349.5 billion |
2.50% |
21.83
|
1 |
37 |
26%
|
|
ROG.SW Roche Holding AG
|
317.6 billion |
3.06% |
20.11
|
1 |
32 |
1%
|
|
RO.SW Roche Holding AG
|
348.0 billion |
2.75% |
21.99
|
1 |
32 |
1%
|
|
SANOFI.BO Sanofi India Limited
|
970.7 million |
0.00% |
26.34
|
2 |
26 |
30%
|
|
SANOFICONR.NS Sanofi Consumer Healthcare India Ltd.
|
1.0 billion |
1.29% |
45.07
|
1 |
2 |
-
|
|
SANOFI.NS Sanofi India Limited
|
913.3 million |
5.03% |
24.68
|
2 |
24 |
30%
|
|
SAN.PA Sanofi
|
108.0 billion |
0.00% |
19.78
|
1 |
27 |
4%
|
|
SCLX Scilex Holding Company
|
81.2 million |
0.00% |
-
|
- |
- |
-
|
|
SCLXW Scilex Holding Company
|
66.3 million |
0.00% |
-
|
- |
- |
-
|
|
SENORES.NS Senores Pharmaceuticals Ltd.
|
352.9 million |
0.00% |
28.71
|
- |
- |
-
|
|
SMSPHARMA.BO SMS Pharmaceuticals Limited
|
365.3 million |
0.11% |
37.42
|
1 |
13 |
10%
|
|
SMSPHARMA.NS SMS Pharmaceuticals Limited
|
375.3 million |
0.10% |
38.45
|
1 |
13 |
10%
|
|
SNPHF Santen Pharmaceutical Co., Ltd.
|
3.5 billion |
2.49% |
21.15
|
3 |
20 |
14%
|
|
SNPHY Santen Pharmaceutical Co., Ltd.
|
4.3 billion |
1.42% |
16.53
|
- |
- |
-
|
|
SNW.DE Sanofi
|
108.3 billion |
0.00% |
19.78
|
1 |
27 |
4%
|
|
SNY Sanofi
|
102.4 billion |
5.68% |
19.84
|
1 |
24 |
4%
|
|
SNYNF SANOFI
|
118.6 billion |
4.07% |
24.26
|
1 |
17 |
2%
|
|
TTKHLTCARE.NS TTK Healthcare Limited
|
126.3 million |
1.16% |
20.26
|
1 |
17 |
9%
|
|
VIRP.PA Virbac S.A.
|
3.4 billion |
0.41% |
19.51
|
1 |
6 |
5%
|
|
VRBCF VIRBAC SA
|
3.3 billion |
0.00% |
-
|
- |
- |
-
|
|
ZEG.DE AstraZeneca PLC
|
285.5 billion |
2.00% |
29.17
|
1 |
26 |
6%
|